TENET HEALTHCARE CORP 8-K

What Happened

• Tenet Healthcare Corporation filed an 8‑K on May 29, 2026 reporting the results of its May 27, 2026 Annual Meeting of Shareholders. All director nominees were elected to serve until the next annual meeting.
• The advisory vote on executive compensation ("say‑on‑pay") was approved with 62,554,346 FOR, 11,817,273 AGAINST and 39,895 ABSTAIN (approximately 84.1% support of votes cast). Shareholders also ratified Deloitte & Touche LLP as Tenet’s independent registered public accountants for 2026 with 79,422,386 FOR, 470,477 AGAINST and 29,318 ABSTAIN (≈99.4% support).
• Broker non‑votes of 5,510,667 were recorded for the director elections and the advisory vote.

Key Details

• Directors elected (each to serve until the next annual meeting): Saumya Sutaria; J. Robert Kerrey; Vineeta Agarwala; James L. Bierman; Roy Blunt; Richard W. Fisher; Meghan M. FitzGerald; Cecil D. Haney; Christopher S. Lynch; Richard J. Mark; Tammy Romo; Nadja Y. West. (Vote totals for each nominee were filed in the 8‑K.)
• Say‑on‑pay vote totals: FOR 62,554,346; AGAINST 11,817,273; ABSTAIN 39,895; Broker non‑votes 5,510,667.
• Auditor ratification vote totals: FOR 79,422,386; AGAINST 470,477; ABSTAIN 29,318 (no broker non‑votes reported for this item).
• 8‑K signed May 29, 2026 by Thomas Arnst, EVP, Chief Administrative Officer, General Counsel and Corporate Secretary.

Why It Matters

• Board continuity: The election of all nominees maintains Tenet’s current board composition, which matters for oversight and strategic direction.
• Executive pay approval: The say‑on‑pay advisory passed with strong majority support (~84%), indicating shareholder affirmation of the company’s executive compensation approach, though a meaningful minority opposed it.
• Auditor confirmation: Ratification of Deloitte ensures continuity of the company’s independent audit relationship for 2026, an important governance and financial reporting matter for investors.